Warburg and Advent in the lead to acquire Baxter’s biopharma unit
Reuters was first to report on Sunday that a private equity consortium comprising Warburg Pincus and Advent International was in advanced talks to acquire medical device maker Baxter International Inc’s BAX.N biopharma solutions business in a deal that could exceed $4 billion. Warburg Pincus and Advent submitted the most attractive offer to Baxter in an […]

